Pacira director Thomas Wiggans files Form 3

Pacira BioSciences, Inc. director Thomas G. Wiggans filed a Form 3, which is an initial statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

Pacira BioSciences, Inc. director Thomas G. Wiggans filed a Form 3, which is an initial statement of beneficial ownership for insiders. The filing shows no reported transactions, with zero shares listed as bought, sold, acquired, or disposed in the transaction summary.

Key Figures

Net buy/sell shares: 0 shares

1 metrics

Net buy/sell shares 0 shares Form 3 transaction summary

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Pacira BioSciences (PCRX) Form 3 for Thomas G. Wiggans show?

The Form 3 for Pacira BioSciences director Thomas G. Wiggans is an initial beneficial ownership filing. It reports no transactions, with zero shares bought, sold, acquired, or disposed according to the transaction summary fields provided.

Did Pacira BioSciences (PCRX) director Thomas G. Wiggans buy or sell any shares in this Form 3?

No, the Form 3 for director Thomas G. Wiggans reports no transactions. The transaction summary shows zero shares bought, sold, acquired, disposed, exercised, gifted, or withheld for taxes in this filing.

What is the purpose of the Form 3 filed for Pacira BioSciences (PCRX)?

The Form 3 serves as an initial statement of beneficial ownership for an insider of Pacira BioSciences. It identifies Thomas G. Wiggans as a director and establishes a baseline, with no share transactions reported in the transaction summary fields.

Does the Pacira BioSciences (PCRX) Form 3 indicate any derivative securities for Thomas G. Wiggans?

No, the derivative summary in the Form 3 is empty. That means the filing does not list any derivative positions such as options or warrants for director Thomas G. Wiggans based on the provided data fields.

What does the transaction summary in the Pacira BioSciences (PCRX) Form 3 indicate?

The transaction summary indicates zero activity across all categories. Buy, sell, acquire, dispose, exercise, gift, tax withholding, and restructuring counts and share amounts are all reported as zero, with a neutral net buy/sell direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 09:05 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

WIGGANS THOMAS G

(Last) (First) (Middle)

C/O PACIRA BIOSCIENCES, INC.

2000 SIERRA POINT PARKWAY, SUITE 900

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
Pacira BioSciences, Inc. [ PCRX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Kristen Williams, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)